Home > News > AMER and NanobacLabs Sign Letter of Intent
May 29th, 2003
AMER and NanobacLabs Sign Letter of Intent
Abstract:
American Enterprise Corporation announced today that it has signed a letter of intent to acquire controlling interest in NanobacLabs Pharmaceuticals, Inc. through a common stock share exchange. NanobacLabs is a private biotechnology and nanotechnology specialty pharmaceutical company based in Tampa, Florida.
Source:
Businesswire
Bookmark:
| Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||